Managing Unusual Sensory Experiences (sometimes called hallucinations), using a new treatment manual, in people who are showing early symptoms that could develop into psychosis

Not Applicable

Completed

• Conditions: Hallucinations; Mental and Behavioural Disorders

• Registration Number: ISRCTN10484951
• Lead Sponsor: orthumberland, Tyne and Wear NHS Foundation Trust

Brief Summary

2020 Results article in https://pubmed.ncbi.nlm.nih.gov/33320425/ (added 08/06/2021)

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2019-01-17
• Study Completion: 2019-10-15
• Last Update Posted: 12 September 2022

Recruitment & Eligibility

• Status: Completed
• Sex: All
• Target Recruitment: 24

Inclusion Criteria

Participants will:
1. Be in contact with Early Intervention in Psychosis services and accepted on the ARMs pathways following assessment by the Comprehensive Assessment of At Risk Mental state (CAARMs)
2. Have a history of hallucinations for at least six weeks or a recent history of brief but intense hallucinations.
3. Be aged 16 and above
4. Consider their unusual sensory experiences (voices or visions) as a main presenting difficulty, and indicate that they would like to receive a psychological intervention specifically designed to address hallucinations
5. Have the capacity to provide informed consent
6. Be judged by their clinician to be clinically stable for the preceding 4 weeks

Exclusion Criteria

Potential participants will not be eligible if:
1. The experience of hallucinations/psychosis has a strong biological basis (owing to traumatic brain injuries, organic psychoses, or dementia)
2. They have insufficient command of English to complete the research interviews and measures
3. They have an intellectual disability, or severe cognitive dysfunction that might preclude their ability to provide informed consent, understand the study procedure and/or fully appreciate the potential consequences of their participation
4. They have a primary diagnosis of substance misuse dependency
5. They are identified by the care team as being too acutely unwell to participate in the research

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Psychotic symptoms measured by the Psychotic Symptom Rating Scale (PSYRATS) both before and after the treatment